Corestemchemon (XKRX:166480) Other Operating Expense : ₩5,577 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Corestemchemon Other Operating Expense?

Corestemchemon's Other Operating Expense for the three months ended in Mar. 2025 was ₩270 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩5,577 Mil.

Corestemchemon's quarterly Other Operating Expense declined from Sep. 2024 (₩2,467 Mil) to Dec. 2024 (₩1,148 Mil) and declined from Dec. 2024 (₩1,148 Mil) to Mar. 2025 (₩270 Mil).

Corestemchemon's annual Other Operating Expense declined from Dec. 2022 (₩7,685 Mil) to Dec. 2023 (₩6,927 Mil) and declined from Dec. 2023 (₩6,927 Mil) to Dec. 2024 (₩5,869 Mil).

Corestemchemon Other Operating Expense Historical Data

The historical data trend for Corestemchemon's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corestemchemon Other Operating Expense Chart

Corestemchemon Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

3,890.21

4,151.60

7,685.06

6,927.42

5,868.71

Corestemchemon Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															690.01	1,692.19	2,467.27	1,148.14	269.89

Corestemchemon Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,577 Mil.

Corestemchemon Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Corestemchemon's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Corestemchemon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corestemchemon Inc (XKRX:166480) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pangyo 255 beongil 24 I & C Building, 2nd Floor, yeonggi-do, Bundang-gu, Seongnam, Seoul, KOR, 13486

Website

http://www.corestemchemon.com

Corestemchemon Inc is a biopharmaceutical company that researches and commercializes stem cell technology. It has developed NEURONATA-R inj., a stem cell therapy for Lou Gehrig's disease which is a rare incurable disease, for the first ALS treatment. Its stem cell therapeutics for Lou Gehrig's disease have a pipeline of incurable diseases such as lupus, multiple system atrophy, and osteoarthritis, and plans to preoccupy the market by focusing on developing therapies for rare incurable diseases based on a development success reference of stem cell therapy for the Lou Gehrig's disease.

Corestemchemon Headlines

No Headlines